Brazilian Protocol for Sexually Transmitted Infections 2020: human papillomavirus (HPV) infection.


Journal

Revista da Sociedade Brasileira de Medicina Tropical
ISSN: 1678-9849
Titre abrégé: Rev Soc Bras Med Trop
Pays: Brazil
ID NLM: 7507456

Informations de publication

Date de publication:
2021
Historique:
received: 01 02 2021
accepted: 10 03 2021
entrez: 19 5 2021
pubmed: 20 5 2021
medline: 21 5 2021
Statut: epublish

Résumé

This article addresses human papillomavirus (HPV) infection, one of the topics covered by the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health. The Protocol and Guidelines have been developed based on scientific evidence and validated in discussions with specialists. This article presents epidemiological and clinical aspects and guidelines for health service managers and health workers about diagnosing and treating people with papillomavirus infection. This theme is a significant public health issue since it is the most prevalent sexually transmitted infection globally, capable of triggering the oncogenic process of cervical cancer and the possibility of anogenital warts. Important information is presented for gaining knowledge about HPV and action strategies for infection prevention and control, provision of quality care, and effective treatment of the disease. Infection by the human papillomavirus is the sexually transmitted infection of the highest contagion, superior to genital herpes and HIV.

Identifiants

pubmed: 34008731
pii: S0037-86822021000501215
doi: 10.1590/0037-8682-790-2020
pmc: PMC8210485
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2020790

Références

Vaccine. 2012 May 2;30(21):3196-201
pubmed: 22425789
Br J Vener Dis. 1971 Feb;47(1):1-13
pubmed: 5550858
Lancet. 2007 Jul 7;370(9581):59-67
pubmed: 17617273
Lancet Infect Dis. 2015 May;15(5):565-80
pubmed: 25744474
J Pediatr Adolesc Gynecol. 2014 Apr;27(2):67-71
pubmed: 24405635
J Med Virol. 2011 Jan;83(1):127-31
pubmed: 21108349
Diagn Cytopathol. 2014 Mar;42(3):205-12
pubmed: 23897742
Obstet Gynecol Clin North Am. 2008 Dec;35(4):599-614; ix
pubmed: 19061819
Infect Dis Clin North Am. 1987 Mar;1(1):123-43
pubmed: 2848068
Lancet. 2011 Mar 12;377(9769):932-40
pubmed: 21367446
J Infect Dis. 2008 Jan 15;197(2):279-82
pubmed: 18179386
J Low Genit Tract Dis. 2010 Jan;14(1):73-80
pubmed: 20043357
Vaccine. 2006 Aug 31;24 Suppl 3:S3/1-10
pubmed: 16949995
Clin Infect Dis. 2016 Nov 15;63(10):1281-1287
pubmed: 27655996
Clin Infect Dis. 2002 Oct 15;35(Suppl 2):S210-24
pubmed: 12353208
N Engl J Med. 1992 Oct 29;327(18):1272-8
pubmed: 1328880
Sex Transm Infect. 2020 May;96(3):177-183
pubmed: 31371447
Am J Med. 1997 May 5;102(5A):16-20
pubmed: 9217658
J Clin Virol. 2005 Mar;32 Suppl 1:S1-6
pubmed: 15753006
Braz J Infect Dis. 2011 Sep-Oct;15(5):473-7
pubmed: 22230855
Sex Transm Dis. 2016 Feb;43(2 Suppl 1):S53-62
pubmed: 26779688
Vaccine. 2013 Dec 31;31 Suppl 7:H1-31
pubmed: 24332295
Int J Gynecol Pathol. 2011 Mar;30(2):173-84
pubmed: 21293281
Am J Epidemiol. 2006 Mar 15;163(6):534-43
pubmed: 16421235
Lancet Infect Dis. 2015 Nov;15(11):1314-23
pubmed: 26201300
Int J Cancer. 2003 Dec 10;107(5):811-6
pubmed: 14566832
Rev Bras Ginecol Obstet. 2018 Jun;40(6):360-368
pubmed: 29874685
Pediatrics. 2019 Feb;143(2):
pubmed: 30670582
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 15;14(5):415-22
pubmed: 9170415
J Sex Med. 2009 Mar;6(3):633-45
pubmed: 19170869
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259
Arch Pathol Lab Med. 2012 Oct;136(10):1266-97
pubmed: 22742517
BJU Int. 2002 Sep;90(5):498-506
pubmed: 12175386
Vaccine. 2014 Jul 23;32(34):4310-6
pubmed: 24950359
J Community Health. 2013 Dec;38(6):1010-4
pubmed: 23728823
Am J Prev Med. 2012 Jan;42(1):44-52
pubmed: 22176845
Obstet Gynecol. 1984 Jul;64(1):16-20
pubmed: 6330630
J Med Virol. 2017 Dec;89(12):2217-2223
pubmed: 28771777
Hum Vaccin Immunother. 2018 Jan 2;14(1):118-123
pubmed: 29049007
BMJ Open. 2018 Jun 7;8(6):e021170
pubmed: 29880568

Auteurs

Newton Sergio de Carvalho (NS)

Universidade Federal do Paraná, Departamento de Tocoginecologia, Curitiba, PR, Brasil.

Roberto José de Carvalho da Silva (RJCD)

Secretaria de Estado da Saúde, Centro de Referência e Treinamento DST/Aids, São Paulo, SP, Brasil.

Isabel Cristina do Val (ICD)

Universidade Federal Fluminense, Departamento Materno-Infantil, Niterói, RJ, Brasil.

Maria Luiza Bazzo (ML)

Universidade Federal de Santa Catarina, Programa de Pós-Graduação em Farmácia, Florianópolis, SC, Brasil.

Mariângela Freitas da Silveira (MFD)

Universidade Federal de Pelotas, Programa de Pós-Graduação em Epidemiologia, Pelotas, RS, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH